NARI (inarimedical.com) צמיחת רווח נקי למניה השנה
Inari Medical, Inc. (NARI) enjoys impeccable trust from cardiologists due to the safety of its systems. Patent protection and GPO contracts create significant market barriers. Organic growth is complemented by mergers with small, debt-free startups. The annual earnings per share (EPS) change chart visualizes this trend, and -2322.90 indicates the company's current yield level.
פילוחי מדדים פיננסיים ומדדי שוק עבור Inari Medical, Inc. (NARI)
This metric reflects the dynamics of net income per share, which is sensitive to the balance between operating expenses and total annual revenue. This metric measures the growth rate of shareholder value, allowing for an assessment of business scaling efficiency. For Inari Medical, Inc. (NARI), this trend depends directly on the expansion of FlowTriever and ClotTriever systems, which confirms that the relative EPS YoY trend underscores the issuer's resilient market position.
